HROW Stock Summary and Trading Ideas (Harrow | NASDAQ:HROW)

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Harrow trades on the NASDAQ stock market under the symbol HROW.

As of October 5, 2026, HROW stock price climbed to $30.99 with 152,460 million shares trading.

HROW has a beta of 2.34, meaning it tends to be more sensitive to market movements. HROW has a correlation of 0.16 to the broad based SPY ETF.

HROW has a market cap of $1.16 billion. This is considered a Small Cap stock.

Last quarter Harrow reported $71 million in Revenue and -$.46 earnings per share. This beat revenue expectation by $160,904 and missed earnings estimates by -$.22.

In the last 3 years, HROW traded as high as $59.23 and as low as $7.60.

The top ETF exchange traded funds that HROW belongs to (by Net Assets): VTI, IWM, VXF, IWO, XPH.

HROW has underperformed the market in the last year with a price return of -35.1% while the SPY ETF gained +16.7%. HROW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.5% and -6.3%, respectively, while the SPY returned +4.1% and +1.5%, respectively.

HROW support price is $29.59 and resistance is $31.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HROW shares will trade within this expected range on the day.